| |
|
Form Serial Number: |
DB20170822E00064 |
| 1.
Date of relevant event: |
21/08/2017
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
00001 |
| 4.
Name of listed corporation: |
CK Hutchison Holdings Limited |
|
5.
Name of associated corporation of listed corporation: |
Hutchison China MediTech Limited |
|
6.
Registered office: |
P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands |
|
7.
Principal place of business: |
22nd Floor, Hutchison House, 10 Harcourt Road, Hong Kong |
|
8.
Class of shares in which interested: |
Ordinary |
|
9.
Number of issued shares in class: |
60,737,204 |
| 12.
Exchange on which listed: |
London Stock Exchange and Nasdaq Global Select Market |
| 13.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Shih |
| (Other names) |
Edith |
|
|
|
| 16.
Name of director (Chinese): |
施熙德 |
| 17.
Chinese Character Code as printed on HKID Card: |
245735561795 |
|
| 30.
Details of relevant event: |
| |
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
| Long position |
| 11031 | The number of shares in which you are interested has increased because:
you became the holder of, wrote or issued equity derivatives under which (choose one):
you have a right to take the underlying shares |
|
|
|
116 |
USD |
49.8400 |
49.8226 |
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| |
| 31.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 119,884 | 0.19 |
|
| |
| 32.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 120,000 | 0.19 |
|
| |
| 33.
Capacity in which interests disclosed in Box 32 are held: |
| Capacity code | Number of shares |
| | |
|
| |
| 34.
Further information in derivative interests in associated corporation: |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by associated corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| Long position | | 4104 | Listed derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| | | | | | | | | 116 |
|
| |
| 35.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 36.
Further information in relation to interests of corporations controlled by director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
| |
| 37.
Further information in relation to interests held by director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 38.
Further information from a trustee, a beneficiary of a trust, or a person who has set up a discretionary trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 39.
Supplementary information: |
The equity derivatives represent the American Depositary Shares ("ADS") which are traded on the Nasdaq Global Select Market. Each ADS equates to 0.5 ordinary share.
|
| 40.
Log/Serial Number of the previous form: |
|
|
Date of filing this Form 3B: |
22/08/2017
(dd/mm/yyyy)
|
|